MacroGenics Provides Update on Corporate Progress and Second Quarter 2021 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/21/2026
- Wall Street rallies as AI optimism reignites and Treasury yields retreat
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Oil price dips below $100 on hopes of US-Iran diplomacy, partial recovery in Saudi exports
- Paramount, Warner Bros jump on report of settlement progress in merger fight
- Investors may be underpricing how far rate hikes could go, Deutsche says
- Far-left party wins Berlin election, pledging to nationalise housing
- Cybercrime feud erupts on dark web as notorious group claims hijack of rival's website
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Qatar Investment Authority targets $20B partnership with JPMorgan - Bloomberg
- Wall Street rallies as AI optimism reignites and Treasury yields retreat
Macrogenics (MGNX) Misses Q2 EPS by 20c
July 29, 2021 4:49 PM EDTMacrogenics (NASDAQ: MGNX) reported Q2 EPS of ($0.66), $0.20 worse than the analyst estimate of ($0.46). Revenue for the quarter came in at $27.2 million versus the consensus estimate of $30.03 million.
For earnings history and earnings-related data on Macrogenics (MGNX) click here.
... More